alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.37



October 20, 2004



Mr. Alan W. Crellin

21926 Castlehill Court

Ashburn, VA 20147



Dear Al:



As you know, US
Airways, Inc. (the Company) is in the process of implementing its Transformation Plan, which will enable it to compete effectively against the competition, including the increasing number of Low-Cost Carriers (LCCs). A major
portion of the Transformation Plan involves reductions in the Companys employee costs, which means changes in the compensation benefits of all employees, including officers. Specifically, pursuant to the management cost reductions announced on
October 4, 2004:



| | 1. |  | effective October 11, 2004, your salary will be reduced by 10%;
| | -- |  | ---------------------------------------------------------------



| | 2. |  | effective October 11, 2004, the amount contributed to your retirement plan will be reduced by 25%;
| | -- |  | --------------------------------------------------------------------------------------------------



| | 3. |  | effective January 1, 2005, the current system for sick and vacation days will be replaced by a Paid Time Off (PTO) system, under which you will be entitled to twenty-five (25) PTO
days and eight (8) holidays;
| | -- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 4. |  | under the new PTO system, the eight holidays will be New Years Day, Memorial Day, Independence Day, Labor Day, Thanksgiving Day, Christmas Day and two floating holidays; and
| | -- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 5. |  | Section 6 of the Agreement will be applied according to your salary of record prior to reduction.
| | -- |  | -------------------------------------------------------------------------------------------------



By your signature below, you agree that (a) the changes identified in items 1-5 above will not, either separately or in the
aggregate, constitute Good Reason, as that term is defined in the Severance Agreement entered into as of June 26, 2002 between you and the Company, and as subsequently amended as of March 31, 2003 (the Agreement); (b) the
changes identified in items 1-5 do not constitute a breach of the Agreement; and (c) as of the date of this letter, Good Reason does not presently exist with respect to you due to the changes identified in items 1-4 above.



---

Mr. Alan W. Crellin

Page 2

October 20, 2004



This letter will be deemed to constitute a written amendment to your Agreement.



Please acknowledge your agreement to the foregoing by signing and dating this letter in the spaces provided below and
returning it to me.



Sincerely,Elizabeth K. Lanier




|                           
|---------------------------
|AGREED TO AND ACCEPTED THIS
|DATE OF OCTOBER, 2004      
|                           
|                           
|Alan W. Crellin
# Predominantly Black Institutions (PBI) Program

# Formula Grants

## FY 2017 Non Competing Continuation Awards
# C_2019302EN.01000601.xml

| 6.9.2019 | EN | Official Journal of the European Union | C 302/6 |
| --- | --- | --- | --- |

6.9.2019

EN

Official Journal of the European Union

C 302/6

---

Euro exchange rates (1)

5 September 2019

(2019/C 302/06)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1058 |
| JPY | Japanese yen | 117,97 |
| DKK | Danish krone | 7,4588 |
| GBP | Pound sterling | 0,89580 |
| SEK | Swedish krona | 10,6825 |
| CHF | Swiss franc | 1,0863 |
| ISK | Iceland króna | 139,30 |
| NOK | Norwegian krone | 9,9332 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,853 |
| HUF | Hungarian forint | 329,47 |
| PLN | Polish zloty | 4,3399 |
| RON | Romanian leu | 4,7300 |
| TRY | Turkish lira | 6,2835 |
| AUD | Australian dollar | 1,6210 |
| CAD | Canadian dollar | 1,4602 |
| HKD | Hong Kong dollar | 8,6686 |
| NZD | New Zealand dollar | 1,7305 |
| SGD | Singapore dollar | 1,5295 |
| KRW | South Korean won | 1 323,90 |
| ZAR | South African rand | 16,3765 |
| CNY | Chinese yuan renminbi | 7,8996 |
| HRK | Croatian kuna | 7,4033 |
| IDR | Indonesian rupiah | 15 605,38 |
| MYR | Malaysian ringgit | 4,6327 |
| PHP | Philippine peso | 57,412 |
| RUB | Russian rouble | 72,9651 |
| THB | Thai baht | 33,777 |
| BRL | Brazilian real | 4,5036 |
| MXN | Mexican peso | 21,7072 |
| INR | Indian rupee | 79,4125 |

Currency

Exchange rate

USD

US dollar

1,1058

JPY

Japanese yen

117,97

DKK

Danish krone

7,4588

GBP

Pound sterling

0,89580

SEK

Swedish krona

10,6825

CHF

Swiss franc

1,0863

ISK

Iceland króna

139,30

NOK

Norwegian krone

9,9332

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,853

HUF

Hungarian forint

329,47

PLN

Polish zloty

4,3399

RON

Romanian leu

4,7300

TRY

Turkish lira

6,2835

AUD

Australian dollar

1,6210

CAD

Canadian dollar

1,4602

HKD

Hong Kong dollar

8,6686

NZD

New Zealand dollar

1,7305

SGD

Singapore dollar

1,5295

KRW

South Korean won

1 323,90

ZAR

South African rand

16,3765

CNY

Chinese yuan renminbi

7,8996

HRK

Croatian kuna

7,4033

IDR

Indonesian rupiah

15 605,38

MYR

Malaysian ringgit

4,6327

PHP

Philippine peso

57,412

RUB

Russian rouble

72,9651

THB

Thai baht

33,777

BRL

Brazilian real

4,5036

MXN

Mexican peso

21,7072

INR

Indian rupee

79,4125

---

(1)  Source: reference exchange rate published by the ECB.

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Human Genome Research Institute Special Emphasis Panel; dGTEx LDACC RFA—SEP.                    

*Date:*                         February 17, 2021.                    

*Time:*                         1:00 p.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 3100, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Rudy O. Pozzatti, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 3100, Bethesda, MD 20817, (301) 435-1580,                         *pozzattr@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)

Dated: January 22, 2021.

David W. Freeman,

Program Analyst. Office of Federal Advisory Committee Policy.

[FR Doc. 2021-02281 Filed 2-3-21; 8:45 am]

BILLING CODE 4140-01-P
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CHATTEM,
INC.'S UNAUDITED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          NOV-30-1999
<PERIOD-START>                             DEC-01-1998
<PERIOD-END>                               MAY-31-1999
<CASH>                                           4,869
<SECURITIES>                                         0
<RECEIVABLES>                                   59,250
<ALLOWANCES>                                       850
<INVENTORY>                                     22,980
<CURRENT-ASSETS>                                90,456
<PP&E>                                          39,126
<DEPRECIATION>                                  18,870
<TOTAL-ASSETS>                                 489,776
<CURRENT-LIABILITIES>                           64,618
<BONDS>                                        378,547
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,034
<OTHER-SE>                                      35,601
<TOTAL-LIABILITY-AND-EQUITY>                   489,776
<SALES>                                        146,169
<TOTAL-REVENUES>                               146,169
<CGS>                                           38,674
<TOTAL-COSTS>                                  111,411
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              18,148
<INCOME-PRETAX>                                 16,854
<INCOME-TAX>                                     6,337
<INCOME-CONTINUING>                             10,517
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                (2,300)
<CHANGES>                                            0
<NET-INCOME>                                     8,217
<EPS-BASIC>                                        .84
<EPS-DILUTED>                                      .81


</TABLE>
#### 3003.101 Standards of conduct.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 3333 HOLDING
CORPORATION'S DECEMBER 31, 1995, FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000818762
<NAME> 3333 HOLDING CORPORATION
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-1996
<PERIOD-START>                             APR-01-1995
<PERIOD-END>                               DEC-31-1995
<CASH>                                               3
<SECURITIES>                                         0
<RECEIVABLES>                                    7,888
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   8,658
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<COMMON>                                             1
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                         442
<TOTAL-LIABILITY-AND-EQUITY>                     8,658
<SALES>                                          1,546
<TOTAL-REVENUES>                                 1,546
<CGS>                                            1,322
<TOTAL-COSTS>                                    1,322
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    224
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                224
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       224
<EPS-PRIMARY>                                     0.00
<EPS-DILUTED>                                     0.00
        

</TABLE>
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 00-6886

WILLIAM IRVIN MARABLE, SR.,

Petitioner - Appellant,

versus

G. M. HINKLE,

Respondent - Appellee.

Appeal from the United States District Court for the Eastern District of Virginia, at Alexandria. James C. Cacheris, Senior District Judge. (CA-99-765-AM)

Submitted: January 31, 2001 Decided: February 22, 2001

Before WILLIAMS and TRAXLER, Circuit Judges, and HAMILTON, Senior

Circuit Judge.

Dismissed by unpublished per curiam opinion.

William Irvin Marable, Sr., Appellant Pro Se. Thomas Drummond

Bagwell, Assistant Attorney General, Richmond, Virginia, for

Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

William Irvin Marable, Sr., appeals the district court’s order

denying relief on his petition filed under 28 U.S.C.A. § 2254 (West

1994 & Supp. 2000). We have reviewed the record and the district

court’s opinion and find no reversible error. Accordingly, we deny

a certificate of appealability and dismiss the appeal on the reasoning of the district court. See Marable v. Hinkle, No. CA-99-

765-AM (E.D. Va. filed June 12, 2000; entered June 14, 2000). We

also deny Marable’s motions for appointment of counsel and for production of court files or papers. We dispense with oral argument

because the facts and legal contentions are adequately presented in

the materials before the court and argument would not aid the

decisional process.

DISMISSED
# C_2020249EN.01000601.xml

| 29.7.2020 | EN | Official Journal of the European Union | C 249/6 |
| --- | --- | --- | --- |

29.7.2020

EN

Official Journal of the European Union

C 249/6

---

Euro exchange rates (1)

28 July 2020

(2020/C 249/02)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1717 |
| JPY | Japanese yen | 123,34 |
| DKK | Danish krone | 7,4429 |
| GBP | Pound sterling | 0,90968 |
| SEK | Swedish krona | 10,2820 |
| CHF | Swiss franc | 1,0758 |
| ISK | Iceland króna | 158,60 |
| NOK | Norwegian krone | 10,6940 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 26,251 |
| HUF | Hungarian forint | 346,98 |
| PLN | Polish zloty | 4,4054 |
| RON | Romanian leu | 4,8355 |
| TRY | Turkish lira | 8,1283 |
| AUD | Australian dollar | 1,6412 |
| CAD | Canadian dollar | 1,5693 |
| HKD | Hong Kong dollar | 9,0810 |
| NZD | New Zealand dollar | 1,7630 |
| SGD | Singapore dollar | 1,6168 |
| KRW | South Korean won | 1 406,13 |
| ZAR | South African rand | 19,4315 |
| CNY | Chinese yuan renminbi | 8,2041 |
| HRK | Croatian kuna | 7,5070 |
| IDR | Indonesian rupiah | 17 030,66 |
| MYR | Malaysian ringgit | 4,9827 |
| PHP | Philippine peso | 57,664 |
| RUB | Russian rouble | 84,8413 |
| THB | Thai baht | 36,920 |
| BRL | Brazilian real | 6,0650 |
| MXN | Mexican peso | 25,8438 |
| INR | Indian rupee | 87,7140 |

Currency

Exchange rate

USD

US dollar

1,1717

JPY

Japanese yen

123,34

DKK

Danish krone

7,4429

GBP

Pound sterling

0,90968

SEK

Swedish krona

10,2820

CHF

Swiss franc

1,0758

ISK

Iceland króna

158,60

NOK

Norwegian krone

10,6940

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

26,251

HUF

Hungarian forint

346,98

PLN

Polish zloty

4,4054

RON

Romanian leu

4,8355

TRY

Turkish lira

8,1283

AUD

Australian dollar

1,6412

CAD

Canadian dollar

1,5693

HKD

Hong Kong dollar

9,0810

NZD

New Zealand dollar

1,7630

SGD

Singapore dollar

1,6168

KRW

South Korean won

1 406,13

ZAR

South African rand

19,4315

CNY

Chinese yuan renminbi

8,2041

HRK

Croatian kuna

7,5070

IDR

Indonesian rupiah

17 030,66

MYR

Malaysian ringgit

4,9827

PHP

Philippine peso

57,664

RUB

Russian rouble

84,8413

THB

Thai baht

36,920

BRL

Brazilian real

6,0650

MXN

Mexican peso

25,8438

INR

Indian rupee

87,7140

---

(1)  Source: reference exchange rate published by the ECB.

---
ex41.htm


    Exhibit
4.1

    


    NOTE

    


    October
6, 2009

    Beverly
Hills, California

    


    


    FOR VALUE RECEIVED, Forex International
Trading Corp. (the "Maker"), hereby promises to pay RASEL LTD. (the "Payee"), at
such place as Payee may, from time to time, designate, the principal sum of
$25,000 in lawful money of the United States no later than October 6,
2010.

    


    Maker further promises to pay interest
on the unpaid principal balance hereof at the rate of four percent (4%) per
annum, such interest to be paid at maturity.  Interest shall be
calculated on the basis of a 360 day year and actual days elapsed.  In
no event shall the interest charged hereunder exceed the maximum permitted under
the laws of the state of Texas.

    


    This Note can be prepaid in whole or in
part at any time without the consent of the Payee provided that Maker shall pay
all accrued interest on the principal so prepaid to date of such
prepayment.

    


    Notwithstanding the due date of this
Note specified above, the entire unpaid principal balance of this Note and
interest accrued with respect thereto shall be immediately due and payable upon
the occurrence of any of the following:

    


    
      	
               
      

            	
              The
      Maker committing an act of bankruptcy, making an assignment for the
      benefit of creditors or making or sending a notice of intended bulk
      transfer, or if a meeting of creditors is convened or a committee of
      creditors is appointed for, or any petition or proceeding for any relief
      under any bankruptcy, reorganization, insolvency, readjustment of debt,
      receivership, liquidation or dissolution law or statute now or hereinafter
      in effect (whether at law or in equity) is filed or commenced by or
      against Maker or any property of Maker, or the appointment of a receiver
      or trustee for Maker or any property of
Maker.

            


    

    


    The Maker waives demand, presentment,
protest and notice of any kind.

    


    This Note may not be changed, modified
or terminated orally, but only by an agreement in writing, signed by the party
to be charged.

    


    This Note shall be governed by and
construed in accordance with the laws of the state of California and shall be
binding upon the successors, assigns, heirs, administrators and executors of the
Maker and enure to the benefit of the Payee, its successors, endorsees, assigns,
heirs, administrators and executors.

    


    If any term or provision of this Note
shall be held invalid, illegal or unenforceable, the validity of all other terms
and provisions hereof shall in no way be affected thereby.

    


    


    FOREX INTERNATIONAL TRADING
CORP.

    


    


    


    By: /s/ Moshe Schnapp

                                            
Name: Moshe Schnapp

    Title: CEO
Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 1 of 25 PageID #:556

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 2 of 25 PageID #:557

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 3 of 25 PageID #:558

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 4 of 25 PageID #:559

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 5 of 25 PageID #:560

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 6 of 25 PageID #:561

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 7 of 25 PageID #:562

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 8 of 25 PageID #:563

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 9 of 25 PageID #:564

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 10 of 25 PageID #:565

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 11 of 25 PageID #:566

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 12 of 25 PageID #:567

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 13 of 25 PageID #:568

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 14 of 25 PageID #:569

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 15 of 25 PageID #:570

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 16 of 25 PageID #:571

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 17 of 25 PageID #:572

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 18 of 25 PageID #:573

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 19 of 25 PageID #:574

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 20 of 25 PageID #:575

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 21 of 25 PageID #:576

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 22 of 25 PageID #:577

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 23 of 25 PageID #:578

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 24 of 25 PageID #:579

Case: 1:12-cv-05811 Document #: 26-4 Filed: 08/21/12 Page 25 of 25 PageID #:580
In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

___________________________

No. 02-19-00045-CV

___________________________

On Appeal from County Court at Law No. 1

Tarrant County, Texas

Trial Court No. 2017-000715-1

Before Bassel, J.; Sudderth, C.J.; and Womack, J.

Per Curiam Memorandum Opinion

CHARLOTTE CARROLL, Appellant

V.

CLAY COOLEY CHEVROLET, Appellee
2

MEMORANDUM OPINION AND JUDGMENT

We have considered “Plaintiffs Motion to Withdraw Appeal.” We grant the 

motion and dismiss the appeal. See Tex. R. App. P. 42.1(a)(1), 43.2(f).

Appellant must pay all costs of this appeal. See Tex. R. App. P. 42.1(d), 43.4.

Per Curiam

Delivered: March 14, 2019
**Exhibit32.2**

**CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection withthe Annual Report of National Mercantile Bancorp (the “Company”) on Form10-KSB/A for the period ending December 31, 2005 as filed with the Securitiesand Exchange Commission on the date hereof (the “Report”), I, David R. Brown,Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350,as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)  The Report fully complies with therequirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;and

(2)  The information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 
|                          |   | /s/ DAVID R. BROWN      |   |
|--------------------------|--------|-------------------------|--------|
|                     |   | David R. Brown          |   |
|                     |   | Chief Financial Officer |
|                     |   |                    |
|                     |   |                    |
| Date: September 28, 2006 |   |                    |

 

----